Category Archives: Biotechnology

The global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021

bioprocess-technologyThe global top 10 bioprocess technology market is expected to reach USD 71.03 billion by 2021 from USD 39.30 billion in 2016, at a CAGR of 12.4% from 2016 to 2021.

On the basis of type, the market is segmented into cell culture, cell expansion, cell counting, flow cytometry, single-use bioprocessing, cell line development, virus filtration, biologics safety testing, pyrogen testing, and tangential flow filtration. In 2016, the cell culture segment is expected to account for the largest share of the global top 10 bioprocess technology market.

Request for Sample Report@http://www.aarkstore.com/sample/381092
On the basis of region, the market is segmented into North America, Europe, Asia, and RoW. In 2016, North America is expected to account for the largest share of the global top 10 bioprocess technology market. This growth can be attributed to the increased R&D spending by pharmaceutical and biotechnology companies in this region.

The growth of this market is mainly driven by rapid growth in pharmaceutical and biotechnology industries, growth in the number of new drug launches, strong trend of R&D in life sciences research, increasing government support for pharmaceutical and biotechnology industries, and high prevalence and large economic burden of chronic diseases.

Research Coverage:

This report studies the top 10 bioprocess technology market based on type and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:

• Product Development/Innovation: Product portfolios of the top players in the top 10 bioprocess technology market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market

• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the top 10 bioprocess technology market

Related Market Research Reports

Top 10 Mobility Technologies Market – Global Forecast to 2022

China Tryptophan Market Research Report 2017

Advertisements

Vaccines Market by Technology , Disease Indication , End User & Type – Forecasts to 2021

Vaccines Market

Summary:

The vaccines market is expected to reach USD 48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3%. The global vaccines market is segmented based on technology, type, disease indication, end-users, and regions. The conjugate vaccines segment is expected to register the highest growth rate in the vaccines market, by technology, during the forecast period. The high growth in this segment is attributed to the increasing company investments in development of new vaccines.

Based on end-users, the vaccines market is segmented into paediatrics and adults. The paediatrics segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases in children and the rising number of awareness programs to promote vaccination will drive the growth of this market.
Geographically, the vaccines market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising government funding for vaccine research in the North American countries.

The major factors contributing to the growth of the vaccines market include high prevalence of diseases, rising government and nongovernment funding for vaccine development, and increasing focus on immunization programs. Furthermore, increasing R&D spending and new vaccine development activities by companies is another major factor driving the growth of this market.
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.
The major players in this market include Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), GlaxoSmithKline, plc. (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur (France), and Serum Institute of India Pvt. Ltd. (India).

The Market Report provides Insights On The Following Pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the vaccines market. The report analyses the vaccines market by technology, type, disease indication, end-users, and regions
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the vaccines market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vaccines market
• Market Development: Comprehensive information about emerging markets. This report analyses the market for various vaccines across geographies
• Market Diversification: Exhaustive information about new vaccines, untapped geographies, recent developments, and investments in the vaccines market

Browse The full Market Research Report @ http://goo.gl/IwtUeI

Reasons To Buy The Market Research Report:

This Market Research report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

Best Selling Reports :

Global Pneumococcal Vaccines Sales Market Report 2021

Global MMRV Vaccines Sales Market Report 2021

Global Meningococcal Vaccines Sales Market Report 2021

Global Biosimilars Market Value Could Hit $55 Billion by 2020

Biosimilars – Regulatory Framework and Pipeline Analysis

The value of the global biosimilars market is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a promising pipeline in active developments and government efforts to reduce healthcare spending. Biologics currently account for between 17–20% of the pharmaceutical arena, with a value of nearly $200 billion, and these products may replace 70% of chemical drugs in the next two decades. The 30% to 50% reduction in biosimilar prices compared with branded biologics could lead to considerable savings in healthcare expenditure.

Biosimilars – Regulatory Framework and Pipeline Analysis report provides a regulatory overview and market outlook for biosimilars, both globally and across the major markets of Europe, the US, India, South Korea, Japan, and China.

http://www.aarkstore.com

The report will allow you to:

  • Understand the regulatory requirements and framework that facilitates effective product development strategy
  • Analyse the details of the clinical pipeline that includes late stage products, Phase II, and Phase I products
  • Examine the biosimilars pipeline, evaluate the products that are highly targeted, analyse the focused indications, therapy areas and the mechanism of actions
  • Understand the pipeline that will help in targeting products for development, rate current products and predict the competition

Find out how Biosimilars are providing a base for reducing the healthcare expenditure in developed markets.

%d bloggers like this: